생물학적 안전 캐비닛 시장 보고서 : 유형별, 최종사용자별, 지역별(2025-2033년)

The global biological safety cabinet market size reached USD 255.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 451.3 Million by 2033, exhibiting a growth rate (CAGR) of 6.22% during 2025-2033.

A biological safety cabinet (BSC) refers to a ventilated laboratory workspace designed for protecting workers and equipment from contamination through various pathogens. The cabinets minimize the biological exposure from harmful viruses, bacteria and other microorganisms. They are classified into three classes I, II and III. Class I cabinets protect the user and the surrounding environment. Class II cabinets protect the user, environment and the samples and are used for low to moderate risk biological agents and class III cabinets offer maximum protection through gas-tight enclosures. They can be customized to provide different protection levels to obtain optimum control over product quality and minimize the potential risks of contamination.

The increasing risks of communicable diseases, along with the on-going viral pandemic, is among the key factors driving the growth of the market. As the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for BSCs in healthcare centers. Furthermore, the rising requirement to safeguard the product, personnel and environment from biohazard exposure and cross-contamination is providing a thrust to the market growth. BSCs are widely used by diagnostic labs and pharmaceutical manufacturers to maintain the microbiological quality of drugs. Additionally, various product innovations, such as the development of cabinet variants with improved construction, airflow pattern, velocities and exhaust systems, are acting as other growth-inducing factors. They are also equipped with digital interfaces for easy control of the cabinet and high-efficiency particulate air (HEPA) filters to maintain the sterility of the environment. Other factors, including the rapid modernization of laboratory equipment, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

Breakup by Type:

• Class I
• Class II
  • Class II Type A
  • Class II Type B
• Class III

Breakup by End User:

• Pharmaceutical and Biopharmaceutical Companies
• Diagnostic and Testing Laboratories
• Academic and Research Institutions

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Air Science, Berner International, BIOBASE, Esco Micro Pte Ltd., EUROCLONE SPA (AddLife Development AB), Germfree Laboratories, Kewaunee Scientific Corporation, Labconco, NuAire (Polypipe), The Baker Company, Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

• How has the global biological safety cabinet market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global biological safety cabinet market?
• What are the key regional markets?
• What is the breakup of the market based on the type?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global biological safety cabinet market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Biological Safety Cabinet Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Class I
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Class II
  • 6.2.1 Market Trends
  • 6.2.2 Major Types
    • 6.2.2.1 Class II Type A
    • 6.2.2.2 Class II Type B
  • 6.2.3 Market Forecast
• 6.3 Class III
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by End User

• 7.1 Pharmaceutical and Biopharmaceutical Companies
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Diagnostic and Testing Laboratories
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Academic and Research Institutions
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Air Science
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
  • 13.3.2 Berner International
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 BIOBASE
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
  • 13.3.4 Esco Micro Pte Ltd.
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
  • 13.3.5 EUROCLONE SPA (AddLife Development AB)
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
  • 13.3.6 Germfree Laboratories
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
  • 13.3.7 Kewaunee Scientific Corporation
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 Financials
  • 13.3.8 Labconco
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
  • 13.3.9 NuAire (Polypipe)
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
  • 13.3.10 The Baker Company, Inc.
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
  • 13.3.11 Thermo Fisher Scientific Inc.
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio
    • 13.3.11.3 Financials
    • 13.3.11.4 SWOT Analysis